Hashimoto’s Thyroiditis

Hashimoto’s Thyroiditis


HASHIMOTO’S THYROIDITIS

ETIOLOGY OF HASHIMOTO’S THYROIDITIS

  • It is an autoimmune disease –
  • It is thought to be initiated by activation of CD4+T (helper) lymphocytes which further recruit cytotoxic CD8+T cells.
  • Thyroid tissue is destroyed by cytotoxic T cells and autoantibodies

Autoantibodies are directed against following antigens.

  • Thyroglobulin (Tg) 60%
  • Thyroid peroxidase (TPO) 95%
  • TSH-R, 60%
  • Antibodies are directed less commonly against the sodium/iodine symporter (25%).

Apoptosis (programmed cell death) is also implicated in the pathogenesis of Hashimoto’s thyroiditis.

Genetic association has been noted with

  • HLA (B8, DR3, DR4 & DR5)
  • CTLA-4 (a T cell regulating gene)

Several chromosomal abnormalities have been associated with Hashimoto’s thyroiditis

  • Turner syndrome
  • Down syndrome

PATHOLOGY OF HASHIMOTO’S THYROIDITIS

1. Gross features

  • Diffuse symmetrically enlarged thyroid.
  • Capsule is intact

2. Microscopic features:

  • Diffuse lymphocytic infiltration with germinal center formation and obliteration of thyroid follicles by widespread apoptosis.
  • The thyroid follicles are atrophic, lined by Hurthle  cells.                    
  • Hurthle cells or Askanazy cells are metaplastic transformation of follicular cells. They have abundant eosinophilic granular cytoplasm (eosinophilic appearance is due to abundance of mitochondria in the cytoplasm).
    • Hurthle cells are virtually pathognomonic – scanty or no colloid within the follicle.
  • There is mild to moderate: fibrosis (but not to the extent seen in Riedel’s thyroiditis)
  • Presence of Hurthle cells and lymphocytes on FNAC is characteristic of Hashimoto thyroiditis.

Thyroid Bcell lymphoma is a rare but well recognized complication of Hashimoto’s thyroiditis..

Papillary thyroid carcinoma may also be occasionally associated.

CLINICAL PRESENTATION OF HASHIMOTO’S THYROIDITIS

  • Like other autoimmune disease, more common in women (Male female ratio 1:10)
  • Age :30-50 yrs.
  • Most common presentation is that of a minimally or moderately enlarged firm gland  with tenderness20% of patients present with hypothyroidism, and 5% present with hyperthyroidism (hashitoxicosis)!

On examiantion an enlarged pyramidal lobe is often palpable.

  • Mild hyperthyroidism may be present initially (d/t destruction of thyroid tissue) but hypothyroidism is inevitable and usually permanent.
  • Thyroid-associated ophthalmopathy is rare in patients with chronic autoimmune thyroiditis

INVESTIGATIONS IN A CASE OF HASHIMOTO’S THYROIDITIS

Laboratory findings are:

  • Elevated TSH, reduced T4 & T3 levels.
  • presence of thyroid autoantibodies (particularly TPO antibody)

In cases of doubt, diagnosis is confirmed by FNA biopsy.

MANAGEMENT IN A CASE OF HASHIMOTO’S THYROIDITIS

  • Thyroid hormone replacement therapy for overtly hypothyroid patients or in euthyroid patients to shrink large goiters.
  • Surgery may occasionally be indicated for suspicion of malignancy or for goiters causing compressive symptoms or cosmetic deformity.

Exam Important

  • Follicular destruction ,Increase in lymphocytes ,Oncocytic metaplasia is seen in Hashimoto’s Thyroiditis.
  • Orphan Annie eye nuclei is not seen in Hashimoto’s Thyroiditis.
  • Thyroid follicular infiltration by lymphocytes along with the presence of Hurthle cells is characteristic of Hashimoto’s disease.
  • Hashimoto’s thyroiditis is an autoimmune disorder.
  • In case of an Autoimmune disease,following is present: T cells recognise self antigen , Hashimoto’s thyroiditis is an example, Polyclonal B cell activation.
  • Higher incidence among females is present in an Autoimmune disease.
  • In hashimoto’s disease serum antibodies are mainly against Thyroid follicles and thyroglobulin.
  • There is increased risk of developing B-cell lymphoma in Hashimoto’s thyroiditis.
  • ‘Hurthle cells’ are seen in Hashimoto’s thyroiditis.
  • Most common cause of Thyroiditis is Hashimoto’s thyroiditis.
  • Antithyroid nuclear antibodies are not seen in Hashimoto’s thyroiditis.
  • Antithyroid microsomal antibodies ,Anti TSH receptor antibodies and Increased level of thyroid hormones may be seen in Hashimoto’s thyroiditis.
  • Enlargement of thyroid gland with tenderness is most commonly seen in Hashimoto’s thyroiditis. 
  • Anti-TPO antibodies are present in Hashimoto’s thyroiditis.
Don’t Forget to Solve all the previous Year Question asked on Hashimoto’s Thyroiditis
Click Here to Start Quiz

Module Below Start Quiz

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support